press release: Access Pharmaceuticals, Inc. Presents MuGard Clinical Experience at MASCC Conference - MarketWatch Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, June 24, 2010

press release: Access Pharmaceuticals, Inc. Presents MuGard Clinical Experience at MASCC Conference - MarketWatch



"MuGard is indicated in Europe for the prevention and management of oral mucositis, and has been used by over 2,000 cancer patients globally. A total of 185 documented patients from various studies utilized MuGard in both prophylactic and curative settings"

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.